Biopharma Insights - page 17

Neuralink's Journey and the Broadening Horizons of Brain-Computer Interface Technology

Neuralink, Elon Musk's brain-implant company, has just revealed that it received approval from the U.S. Food and Drug Administration (FDA) for its inaugural human clinical trial. This development, disclosed on …

Continue ›››

Valo Therapeutics' Innovative Immuno-Oncology Therapy PeptiCRAd-1 Begins Human Trials

Valo Therapeutics Oy (ValoTx), a frontrunner in the development of advanced immunotherapies for cancer, has initiated its Phase I trial of PeptiCRAd-1, a pioneer in the realm of immuno-oncology. The …

Continue ›››

How Syntekabio’s Supercomputing Enables AI-driven Drug Discovery

FDA Recognizes SiSaf's siRNA Therapy, SIS-101-ADO, for Autosomal Dominant Osteopetrosis Treatment

In a noteworthy development in the pharmaceutical industry, SiSaf Ltd, a renowned RNA delivery and therapeutics firm, recently announced that the U.S. FDA has granted Orphan Drug Designation and Rare …

Continue ›››

LabGenius Showcases AI-Driven Antibody Discovery Platform in a T-cell Engager Demonstration

London-based LabGenius, known for its innovative approach to antibody discovery, recently revealed impressive results from its research platform demonstration project. This project showcased the company's machine learning-driven lead optimization capacity, …

Continue ›››

Bruker Acquires ZONTAL, Boosting Digital Transformation in Pharma Laboratories

The pharmaceutical industry is undergoing a significant shift as digital transformation in pharma continues to reshape the landscape. Bruker Corporation, a leading provider of high-performance scientific instruments and solutions, recently …

Continue ›››

Advancing Cell-free Biocomputing

Researchers from the University of Minnesota have published a study in Nature Communications introducing a new biocomputing method, Transcriptional RNA Universal Multi-Purpose GatE PlaTform (Trumpet), which leverages biological enzymes as …

Continue ›››

From Qubits to Cures: The Promise of Quantum Computing in Pharmaceutical Research and Development (a Realistic View)

In a recent announcement, Moderna and IBM unveiled their partnership aimed at utilizing cutting-edge technologies, such as artificial intelligence (AI) and quantum computing, to accelerate research in messenger RNA (mRNA) …

Continue ›››

The Power of STB CLOUD in Remote AI Drug Discovery

AI Drug Discovery: Unleashing the Potential of Big Data and Machine Learning

The terms “big data”, “machine learning”, and “artificial intelligence” have been trending in the AI drug discovery space for several years, both in mainstream media and academic press. These new …

Continue ›››

RetinAI and Boehringer Ingelheim Collaborate on AI-Driven Drug Discovery for Geographic Atrophy Treatment

Established in 2017 in Swiss, RetinAI Medical AG is a notable player in clinical and imaging data management software and advanced analytics using artificial intelligence (AI) for ophthalmology, which has …

Continue ›››

Myricx Pharma Showcases Promising Pre-Clinical Data for NMTi ADC Programme at AACR

Myricx Pharma, an oncology drug discovery company specializing in precision medicines based on its N-myristoyltransferase (NMT) platform, has recently presented positive pre-clinical proof of concept data at the American Association …

Continue ›››